You are here

Toxicologic Pathology

Toxicologic Pathology

2017 Impact Factor: 1.966
2017 Ranking: 65/94 in Toxicology | 41/79 in Pathology
Source: Journal Citation Reports®, 2018 release, a Clarivate Analytics product; Indexed in PubMed: MEDLINE
Published in Association with Society of Toxicologic Pathology
Published in Association with British Society of Toxicological Pathology
Published in Association with European Society of Toxicologic Pathology

Editor
Susan A. Elmore, MS, DVM, DACVP, DABT, FIATP Research Triangle Park, NC, USA


eISSN: 15331601 | ISSN: 01926233 | Current volume: 46 | Current issue: 6 Frequency: 8 Times/Year

Toxicologic Pathology is dedicated to the promotion of human, animal, and environmental health through the dissemination of knowledge, techniques, and guidelines to enhance the understanding and practice of toxicologic pathology.

Toxicologic Pathology, the official journal of the Society of Toxicologic Pathology, the British Society of Toxicological Pathology and the European Society of Toxicologic Pathology, will publish Original Research Articles, Symposium Articles, Review Articles, Meeting Reports, New Techniques, and Position Papers that are relevant to toxicologic pathology. Relevant topics include reports on safety assessment of pharmaceuticals, chemicals, food additives, pesticides, environmentally relevant chemicals, and medical devices; risk characterization of xenobiotics; investigative studies that contribute to refinement of the safety assessment process; mechanistic studies that provide a basis for interpreting and predicting toxicologic outcome; emerging approaches and methods in toxicologic pathology; spontaneous diseases that may influence toxicology studies, and animal and alternative models relevant to toxicologic pathology. Studies of botanicals and their extracts must include appropriate characterization of the components and concentration of active ingredients; crude extracts will not be accepted. Reviews may be contributed or invited. This journal is a member of the Committee on Publication Ethics (COPE).


Average time from submission to first decision: 21 days

Among the topics in recent issues are:

  • Adverse Events
  • Angiogenesis Inhibitors
  • Basic and Translational Research
  • Drug Development for Pediatric Populations
  • Drug-Induced Hematologic Toxicity
  • Epigenetics
  • Genomic Analyses
  • Global Regulatory Perspectives
  • Hazard Identification
  • High Throughput Pathology
  • Immunomodulation
  • International Accreditation For Toxicologic Pathologists
  • Lesions
  • Neoplasia and Hyperplasia
  • Risk Assessment
  • Risk Communication
  • Safety Assessments
  • Tumor Pathology
  • Use of Animal Models

Toxicologic Pathology also publishes timely in-depth current topic review papers, symposia papers, brief communications, best practice articles for scientific and regulatory processes, and position papers on current regulatory issues.

Toxicologic Pathology is dedicated to the promotion of human, animal, and environmental health through the dissemination of knowledge, techniques, and guidelines to enhance the understanding and practice of toxicologic pathology.

Toxicologic Pathology, the official journal of the Society of Toxicologic Pathology, the British Society of Toxicological Pathology and the European Society of Toxicologic Pathology, will publish Original Research Articles, Symposium Articles, Review Articles, Meeting Reports, New Techniques, and Position Papers that are relevant to toxicologic pathology. Relevant topics include reports on safety assessment of pharmaceuticals, chemicals, food additives, pesticides, environmentally relevant chemicals, and medical devices; risk characterization of xenobiotics; investigative studies that contribute to refinement of the safety assessment process; mechanistic studies that provide a basis for interpreting and predicting toxicologic outcome; emerging approaches and methods in toxicologic pathology; spontaneous diseases that may influence toxicology studies, and animal and alternative models relevant to toxicologic pathology. Studies of botanicals and their extracts must include appropriate characterization of the components and concentration of active ingredients; crude extracts will not be accepted. Reviews may be contributed or invited. This journal is a member of the Committee on Publication Ethics (COPE).

Average time from submission to first decision: 21 days

Editor in Chief
Susan A. Elmore, MS, DVM, DACVP, DABT, FIATP Research Triangle Park, NC, USA
Managing & Production Editor
Stephanie Dickinson, BA, CAE Toxicologic Pathology Editorial Office, NJ, USA
Illustrations Editor/Cover Design
Beth Mahler Experimental Pathology Labs, NC, USA
Associate Editors
Bindu Bennet, BVSc, AH, MS, PhD Janssen Research and Development, Spring House, PA, USA
Catherine Botteron, DVM, PhD, DECVP Bracco Suisse SA, Switzerland
Denise Bounous, DVM, PhD Bristol Myers Squibb Company, Princeton, NJ, USA
Molly Boyle, DVM, DACVP Envigo, Thousand Oaks, CA, USA
Stacey Fossey, DVM, PhD, DACVP AbbVie, Chicago, IL, USA
Peter Hall, BVetMed, MRCVS, PhD, FRCPath UCB Pharma Ltd., Berkshire, UK
Adam Hargreaves, FRCPath, DACVP PathCelerate Ltd., Cheshire, UK
Jessica Hoane, DVM, DACVP Charles River Laboratories, Durham, NC, USA
Mark Hoenerhoff, DVM, PhD, DACVP, FIATP University of Michigan, Ann Arbor, MI, USA
Kevin Keane, DVM, PhD, FIATP Novo Nordisk Research Centre, Copenhagen, Denmark
James Morrison, DVM, DACVP Charles River Laboratories Pathology, Durham, NC, USA
Abraham Nyska, DVM, FIATP Sackler School of Medicine, Tel Aviv University, Timrat, ISRAEL
George Parker, DVM, PhD, DACVP, DABT, FIATP Charles River Laboratories, Durham, NC, USA
Daniel Rudmann, DVM, PhD, DACVP Flagship Biosciences, Westminter, CO, USA
Rain Sellers, DVM, PhD, DACVP Pfizer Inc., Pearl River, NY, USA
Jerrold M. Ward, DVM, PhD, FIATP Global Vet Pathology, Montgomery Village, MD, USA
Katsuhiko Yoshizawa, DVM, PhD, FIATP Mukogawa Women's University, Hyogo, Japan
Senior Advisors
John R. Foster, BSc, PhD, DipRCPath. FRCPath, FIATP ToxPath Sciences Ltd., UK
James Klaunig, PhD, FIATP Indiana University School of Medicine, USA
Editorial Board
Hibret A. Adissu, DVM, MSc, DVSc, PhD, DACVP NIH/NCI, Bethesda, MD, USA
Shirley Aguirre, DVM, PhD La Jolla Laboratories, San Diego, CA, USA
Duane Belote, DVM, DACVP Covance Laboratories Inc., Chantilly, VA, USA
Lisa Berman-Booty, VMD, PhD, DACVP Bristol-Myers Squibb, New Brunswick, NJ, USA
Brian Berridge, DVM, PhD, DACVP NIEHS, Raleigh, NC, USA
Brad Blakenship, DVM, DACVP Covance, Madison, WI, USA
Rogely Boyce, DVM, PhD, DACVP Amgen Inc., Clay, WV, USA
Cory Brayton, DVM, ACLAM, DACVP Johns Hopkins University School of Medicine, Baltimore, MD, USA
Danielle Brown, DVM, MS, DACVP Charles River Laboratories, Durham, NC, USA
Russ Cattley, VMD, PhD Auburn University, Auburn, AL, USA
Ronnie Chamanza, BVSc, MSc, Dip RC Path, FRCPath, MRCVS Johnson & Johnson, Huntingdon, UK
Sundeep Chandra, BVSc, PhD Biomarin, San Rafael, CA, USA
Franck Chanut, DVM, MSc, DECVP, DESV-AP Sanofi, Paris, France
Shambhunath Choudhary, BVSc, PhD, DACVP Charles River Laboratories, Spencerville, OH, USA
Mark Cline, DVM, PhD, DACVP Wake Forest School of Medicine, Winston-Salem, NC, USA
Samuel M. Cohen, MD, PhD, FIATP University of Nebraska Medical Center, Omaha, NE, USA
Michelle C. Cora, DVM, DACVP NIEHS, Research Triangle Park, NC, USA
Diane Creasy, PhD, FRCPath Envigo, Pipersville, PA, USA
Darlene Dixon, DVM, PhD, DACVP, FIATP NIEHS, NC, USA
Kevin Donnelly, DVM, PhD Theravance Inc., San Francisco, CA, USA
Michael R. Elwell, DVM, PhD, FIATP Covance Laboratories Inc., Vienna, VA, USA
Jeffrey Everitt, DVM, DACVP, DACLAM, FIATP Duke University School of Medicine, Durham, NC, USA
Ken Frazier, DVM, PhD, DAVCP, DABT, FIATP GlaxoSmithKline, King of Prussia, PA, USA
Jurgen Funk, Dr. Med. Vet. Hoffman-LaRoche, Basel, Switzerland
Kathleen A. Funk, DVM, PhD, DACVP Experimental Pathology Laboratories Inc., Sterling, VA, USA
Santokh Gill, PhD Health Canada, Ottawa, Canada
Katheryn Gropp, DVM, PhD, DACVP Pfizer Inc., Groton, CT, USA
Silvia Guionaud, PhD, DECVP AstraZeneca, Cambridge, UK
Jerry Hardisty, DVM EPL Inc., Research Triangle Park, NC, USA
Wanda M. Haschek-Hock, BVSc, PhD, DACVP, DABT, FIATP University of Illinois, Urbana, IL, USA
Armando Irizarry, DVM, PhD, DACVP Eli Lilly & Company, Indianapolis, IN, USA
Kyathanahalli Janardhan, BVSc, MVSc, PhD, DACVP Integrated Laboratory Systems, Research Triangle Park, NC, USA
Takahito Kambara, BVSc, MVSc, PhD, FRCPath AbbVie Inc., North Chicago, IL, USA
Jean-Francis Lafond, DVM, MsC, DES, DACVP Charles River Laboratories, Quebec, Canada
Thomas Lemarchand, DVM, PhD TPL Path Labs, Freiburg, Germany
Barbara Lenz, Dr, met, vet Hoffman-LaRoche, Basel, Switzerland
Elizabeth McInnes, BVSc, PhD, FRCPath, MRCVS, FIATP (Podcast Manager) Gribbles Healthscope, Guildford, UK
Sydney Mukaratirwa, PhD, DACVP, FIATP Envigo, Cambridgeshire, UK
Ricardo Ochoa, DVM, PhD, DACVP, FIATP Pre-Clinical Safety Inc., Niantic, CT, USA
Arun Pandiri, BVSc&AH, MS, PhD, DACVP NIEHS, Research Triangle Park, NC, USA
Daniel Patrick, DVM, DACVP, DABT MPI Research, Mattawan, MI, USA
Shyamal D. Peddada, PhD NIEHS, Research Triangle Park, NC, USA
Jerry Rehg, DVM St. Jude Children's Research Hospital, Memphis, TN, USA
Amera K. Remick, DVM, DACVP, DABT Charles River Laboratories, Durham, NC, USA
Roger Renne, DVM, DACVP Roger Renne ToxPath Consulting, Richland, WA, USA
Susanne Rittinghausen, DVM, Dr. Med. Vet. Habil. Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany
Frederic Schorsch, DVM, Msc Tox Path, DESV Ana-Path, DECVP Bayer CropScience, Antipolis, France
Keith R. Shockley, PhD NIEHS/NIH, Research Triangle Park, NC, USA
Reginald A. Valdez, DVM, MS, PhD, DACVP Novartis Institutes for BioMedical Research, Cambridge, MA, USA
Justin Vidal, DVM, PhD GlaxoSmithKline, King of Prussia, PA, USA
Jeff Wolf, DVM, DACVP Experimental Pathology Laboratories Inc., Sterling, VA, USA
  • AgBiotech News and Information
  • AgBiotechNet
  • Animal Breeding Abstracts
  • Botanical Pesticides
  • CAB Abstracts (Index Veterinarius, Veterinary Bulletin)
  • CAB Health
  • CABI: Abstracts on Hygiene and Communicable Diseases
  • CABI: CAB Abstracts
  • CABI: Dairy Science Abstracts
  • CABI: Global Health
  • CABI: Nutrition Abstracts and Reviews Series A
  • CABI: Review of Aromatic and Medicinal Plants
  • CABI: Tropical Diseases Bulletin
  • Chemical Abstracts Service (CAS)
  • Clarivate Analytics: BIOSIS Previews
  • Clarivate Analytics: Current Contents - Life Sciences
  • EMBASE/Excerpta Medica
  • Helminthological Abstracts
  • MEDLINE
  • NISC
  • Nutrition Abstracts and Reviews Series B
  • Plant Breeding Abstracts
  • Poultry Abstracts
  • ProQuest: CSA Toxicology Abstracts
  • Review of Agricultural Entomology
  • Review of Medical and Veterinary Entomology
  • Review of Medical and Veterinary Mycology
  • Review of Plant Pathology
  • Science Citation Index Expanded (Web of Science)
  • Soils and Fertilizers
  • Soybean Abstracts
  • Toxicology Literature Online (TOXLINE)
  • Weed Abstracts
  • All manuscripts to Toxicologic Pathology should be submitted via the SAGE Track online submission site at https://mc.manuscriptcentral.com/toxpath. The instructions for authors can be downloaded at that site as well.

    Individual Subscription, Print Only


    Institutional Subscription, E-access


    Institutional Subscription, Print Only


    Institutional Subscription & Backfile Lease, E-access Plus Backfile (All Online Content)


    Institutional Subscription, Combined (Print & E-access)


    Institutional Subscription & Backfile Lease, Combined Plus Backfile (Current Volume Print & All Online Content)


    Institutional Backfile Purchase, E-access (Content through 1998)


    Individual, Single Print Issue


    Institutional, Single Print Issue